Troglitazone-Associated Hepatic Failure

  1. Brent A. Neuschwander-Tetri, MD;
  2. William L. Isley, MD; and
  3. Julie C. Oki, PharmD
  1. St. Louis University School of Medicine; St. Louis, MO 63110 (Neuschwander-Tetri) St. Lukes Hospital; Kansas City, MO 64111 (Isley) University of Missouri-Kansas City School of Medicine; Kansas City, MO 64108 (Oki)

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, …

    « Previous | Next Article »Table of Contents